Cofco Reconciled Depreciation from 2010 to 2024

000930 Stock   5.78  0.04  0.69%   
Cofco Biochemical's Reconciled Depreciation is increasing over the years with slightly volatile fluctuation. Reconciled Depreciation is expected to dwindle to about 479.1 M. From 2010 to 2024 Cofco Biochemical Reconciled Depreciation quarterly data regression line had arithmetic mean of  319,704,335 and r-squared of  0.66. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2010-12-31
Previous Quarter
491.8 M
Current Value
479.1 M
Quarterly Volatility
158.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cofco Biochemical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cofco Biochemical's main balance sheet or income statement drivers, such as Interest Expense of 118.4 M, Selling General Administrative of 184.1 M or Total Revenue of 21.4 B, as well as many indicators such as . Cofco financial statements analysis is a perfect complement when working with Cofco Biochemical Valuation or Volatility modules.
  
This module can also supplement various Cofco Biochemical Technical models . Check out the analysis of Cofco Biochemical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Cofco Stock

Cofco Biochemical financial ratios help investors to determine whether Cofco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cofco with respect to the benefits of owning Cofco Biochemical security.